FDA reopens comment period for Transparency Task Force

08/31/2009 | HealthImaging.com

The FDA has reopened the comment period for the Transparency Task Force through Nov. 6 in preparation for a scheduled second public meeting this fall. The agency is seeking comments on how it can make activity and decision-making data available to the public.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN